Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

PCOS is influenced by genetics and lifestyle, causing hormonal imbalances and health risks like diabetes and infertility.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

PCOS causes menstrual issues, infertility, and long-term health risks.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

A new method accurately measures nine specific hormones in human blood.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

PCOS negatively affects women's quality of life, especially if not detected early.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Polycystic Ovarian Syndrome (PCOS) is a common condition causing fertility issues and other symptoms, with unclear causes and treatments focused on improving insulin sensitivity.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.